OBD vs. SBTX, COS, C4XD, DDDD, SAR, FUM, HEMO, APTA, POLB, and AREC
Should you be buying Oxford BioDynamics stock or one of its competitors? The main competitors of Oxford BioDynamics include SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Sareum (SAR), Futura Medical (FUM), Hemogenyx Pharmaceuticals (HEMO), Aptamer Group (APTA), Poolbeg Pharma (POLB), and Arecor Therapeutics (AREC). These companies are all part of the "biotechnology" industry.
Oxford BioDynamics vs. Its Competitors
Oxford BioDynamics (LON:OBD) and SkinBioTherapeutics (LON:SBTX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.
SkinBioTherapeutics has higher revenue and earnings than Oxford BioDynamics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.
Oxford BioDynamics has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, SkinBioTherapeutics has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500.
11.4% of Oxford BioDynamics shares are held by institutional investors. Comparatively, 2.3% of SkinBioTherapeutics shares are held by institutional investors. 15.5% of Oxford BioDynamics shares are held by insiders. Comparatively, 2.7% of SkinBioTherapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
SkinBioTherapeutics has a net margin of -237.95% compared to Oxford BioDynamics' net margin of -1,800.32%. SkinBioTherapeutics' return on equity of -115.86% beat Oxford BioDynamics' return on equity.
In the previous week, Oxford BioDynamics' average media sentiment score of 0.00 equaled SkinBioTherapeutics'average media sentiment score.
Summary
SkinBioTherapeutics beats Oxford BioDynamics on 7 of the 11 factors compared between the two stocks.
Get Oxford BioDynamics News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford BioDynamics Competitors List
Related Companies and Tools
This page (LON:OBD) was last updated on 9/13/2025 by MarketBeat.com Staff
